Cargando…
Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia
SIMPLE SUMMARY: Head and neck cancer patients face significant morbidity and mortality. Early detection and diagnosis of disease followed by timely intervention is necessary for improving clinical management for these patients. There remains a need to be able to identify whether an early pre-cancero...
Autores principales: | Ranganath, Kushi, Feng, Allen L., Franco, Ramon A., Varvares, Mark A., Faquin, William C., Naunheim, Matthew R., Saladi, Srinivas Vinod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688631/ https://www.ncbi.nlm.nih.gov/pubmed/36428690 http://dx.doi.org/10.3390/cancers14225581 |
Ejemplares similares
-
Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
por: Park, Jong Chul, et al.
Publicado: (2022) -
Protocol for Bulk-ATAC sequencing in head and neck squamous cell carcinoma
por: Chen, Nana, et al.
Publicado: (2023) -
Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2022) -
Identification of molecular signature of head and neck cancer stem-like cells
por: Shrivastava, Shubham, et al.
Publicado: (2015) -
Malignant transformation of fibrous dysplasia: A case report
por: HATANO, HIROSHI, et al.
Publicado: (2014)